GPC3 and hepatocellular carcinoma: For HCC, early stage clinical trials are exploring new targets (46) such as glycoprotein 3 (GPC3) - a molecule that is highly expressed on most HCC cells, as a potential therapeutic target (47) GPC3 is the first molecule that is highly expressed on most HCC cells and is a potential therapeutic target.